☆ 4.5 Review

Current status of gendicine in China: Recombinant human Ad-p53 agent for treatment of cancers

HUMAN GENE THERAPY (2005)

Get Full Text
Add to Collection

Journal

HUMAN GENE THERAPY
Volume 16, Issue 9, Pages 1016-1027

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/hum.2005.16.1016

Keywords

-

Categories

Biotechnology & Applied Microbiology Genetics & Heredity Medicine, Research & Experimental

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.